Abstract
The detection of 19 norandrosterone (19-NA) in a competitor's urine sample is taken as prima facie evidence of administration of nandrolone or other 19-norsteroid but a potential problem is that administration of norethisterone, a progestogen used for menstrual disorders and for hormonal contraception, also results in the excretion of 19-NA that can exceed the laboratory reporting threshold of 2 ng/mL The contribution of norethisterone to urinary 19-NA with and without 19-norandrostenedione. a known norethisterone tablet impurity, requires evaluation. Preparations containing, either
Original language | English |
---|---|
Pages (from-to) | 341 - 349 |
Number of pages | 9 |
Journal | Steroids |
Volume | 74 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2009 |